Sanaria Readies New Malaria Vaccine | Chemical & Engineering News
Volume 85 Issue 45 | p. 11 | Concentrates
Issue Date: November 5, 2007

Sanaria Readies New Malaria Vaccine

Department: Business

Sanaria and the PATH Malaria Vaccine Initiative (MVI) have opened a plant in Rockville, Md., to manufacture the first vaccine using a weakened malaria parasite. Overcoming obstacles to large-scale production, Sanaria's approach involves safely raising aseptically produced mosquitoes carrying Plasmodium falciparum, irradiating them to weaken the parasite, and then harvesting the parasite from the insects' salivary glands. Sanaria plans to begin clinical testing next year. Along with MVI, Sanaria has support from NIH and the Department of Defense.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment